ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 8.66
+0.02 (0.23%)
Jul 14, 2026, 4:00 PM EDT
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 4.31 billion as of July 14, 2026. Its market cap has decreased by -25.60% in one year.
Market Cap
4.31B
Enterprise Value
4.33B
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
8.66
Market Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 4.31B, an increase of 103.37%. That is a compound annual growth rate of 4.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 4.31B | -9.41% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Wecome Pharmaceutical Company | 4.80B |
| Xiangxue Pharmaceutical | 4.77B |
| Hefei Lifeon Pharmaceutical | 4.75B |
| Suzhou Fengbei Biotech Stock | 4.45B |
| Shanghai Serum Bio-Technology | 4.45B |
| Shanghai Obio Technology (Group) Corp. | 4.20B |
| Kexing Biopharm | 4.11B |
| Jiangsu Sihuan Bioengineering | 4.06B |